Hypertension (high blood pressure) Board decisions

The Board denied service connection for obstructive sleep apnea and granted earlier effective dates for the ratings of diabetic peripheral neuropathy in the upper and lower extremities, as well as for hypertension.

The Board dismissed the Veteran's requests for an extension of time to opt into the Appeals Modernization Act (AMA) system as moot because the issues were already adjudicated on the merits in a legacy decision.

The Board remands the claims for service connection for stomach cancer and hypertension to conduct necessary development regarding potential exposures at Fort McClellan.

The Board remands the claims for service connection for heart disease and hypertension to obtain additional medical evidence regarding exposure to commercial herbicides during active service.

The Board granted service connection for hypertension, GERD, and allergic rhinitis with effective dates of April 13, 2023, but denied service connection for hypercholesterolemia. It also granted a 10 percent rating for the Veteran's service-connected hypertension.

The Board granted service connection for diabetes mellitus type II and hypertension, as secondary to the service-connected left ankle strain.

The Board granted service connection for obstructive sleep apnea (OSA) as it was caused by the Veteran's service-connected acquired psychiatric disorder. The other claims for type 2 diabetes mellitus, hypertension, and irritable bowel syndrome were remanded for further examination.

The Board granted service connection for temporomandibular joint (TMJ) disorder as a complication of posttraumatic stress disorder (PTSD), but denied an earlier effective date for the grant of service connection for PTSD and remanded issues related to gastroesophageal reflux disease and hypertension.

The Board denied earlier effective dates for the award of service connection for hypertension and CAD, granted a 10 percent evaluation for hypertension, and remanded several other claims.

The Board denied service connection for epilepsy, bilateral detached retina (previously rated as blurred vision), cervical spine condition, and migraine headaches. However, it granted service connection for hypertension and earlier effective dates for lumbar spine disability, left lower extremity sciatic nerve radiculopathy, right lower extremity sciatic nerve radiculopathy, and PTSD.

The appeal for service connection for hypertension was dismissed due to a claims processing error. The appeals for service connection for bilateral shoulder disability and back disability were denied, while the appeal for sleep disorder was remanded.

The Board granted service connection for the cause of the Veteran's death, which was determined to be related to hypertension presumed due to in-service exposure to herbicide agents.

The Board granted service connection for diabetes mellitus type II, hypertension, chronic kidney disease, anemia, and eye disability as secondary to the Veteran's service-connected bilateral knee disabilities.

The Board granted a separate initial rating of 10 percent for hypertension (as a complication of diabetes) effective November 17, 2023, and denied ratings in excess of the current levels for diabetes mellitus with retinopathy and gastroparesis, neuropathy of the left foot, and entitlement to a total disability rating due to individual unemployability.

The claims for service connection and a total disability rating based on individual unemployability (TDIU) are remanded due to the failure of the Agency of Original Jurisdiction (AOJ) to ensure delivery of the November 2022 supplemental statement of the case to the Appellant.

The Board denied the veteran's claims for increased ratings and other benefits, finding that the evidence did not support higher ratings or additional compensation.

The Board granted service connection for sinusitis and denied a compensable rating for hypertension. The claims for service connection for a psychiatric condition, pre-cancerous growths cysts in upper gum and nasal cavity, obstructive sleep apnea, and muscle weakness were remanded.

The Board denied service connection for chronic fatigue syndrome, chronic sinusitis, an increased rating for hypertension, a compensable evaluation for allergic rhinitis, and increased ratings for sleep apnea syndrome and seasonal dyshidrotic eczema.

The Board granted effective dates of May 31, 2023, for the awards of a 10 percent disability rating for rhinitis and a 50 percent disability rating for migraines. The award of service connection for urinary incontinence was denied an earlier effective date.

The Board granted service connection for hypertension, finding it to be secondary to the Veteran's service-connected low back disability.